Navigation Links
Cornerstone Therapeutics to Host First Quarter 2010 Conference Call
Date:4/26/2010

CARY, N.C., April 26 /PRNewswire-FirstCall/ -- Cornerstone Therapeutics Inc. (Nasdaq: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets, today announced that it will host a conference call at 8:00 AM ET on Tuesday, May 4, 2010, to discuss its financial results for the quarter ended March 31, 2010.  Management will also provide an update on the Company's strategy, operations and product development pipeline.  Cornerstone intends to issue its financial results press release prior to the conference call.

To participate in the live conference call, please dial 866-804-6924 (U.S. callers) or 857-350-1670 (international callers), and provide passcode 80662773.  A live webcast of the call will also be available through the Investor Relations section of the Company's website.  Please allow extra time prior to the webcast to register, download and install any necessary audio software.

The webcast will be archived for 30 days, and a telephone replay of the call will be available for seven days, beginning at 11:30 AM ET on May 4, 2010, by dialing 888-286-8010 (U.S. callers) or 617-801-6888 (international callers), and providing passcode 11546306.

About Cornerstone Therapeutics

Cornerstone Therapeutics Inc. (Nasdaq: CRTX), headquartered in Cary
'/>"/>

SOURCE Cornerstone Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board
2. Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010
3. Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal
4. Cornerstone Therapeutics to Present at the 30th Annual Cowen & Company Health Care Conference
5. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
6. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
7. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
8. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
9. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
10. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
11. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... -- IRIDEX Corporation (Nasdaq: IRIX ) today reported financial ... 2015.  , Revenues were $11.8 million in the ... up 11% from $10.6 million in the 2013 fourth quarter. ... 12% from $38.3 million in 2013. , Gross margin ... in the fourth quarter of the prior year. , ...
(Date:3/5/2015)... 5, 2015 Bayer HealthCare announced today that ... Cancer Foundation of the American Society of Clinical Oncology ... technology platform designed to unlock vast quantities of information ... "Bayer is proud to join ASCO and ... Big Data to help people whose lives have been ...
(Date:3/5/2015)...   AMC Health , the leading provider ... the effectiveness and efficiency of healthcare for high-risk ... and Jared Wilstead have joined the ... Client Development, and Wilstead will serve as Vice ... commitment to accelerating the adoption of monitored care ...
Breaking Medicine Technology:IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 2Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 3AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 2AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 3
... 2010 Mederi Therapeutics Inc announced today that it ... and use of Mederi,s second generation of the Stretta ... of gastric reflux disease, commonly known as GERD, and ... disorder, or BCD.  These latest systems include a streamlined ...
... 8, 2010 DURECT Corporation (Nasdaq: DRRX ... CEO, will be presenting at the Credit Suisse 2010 ... Pacific Time. The conference is being held at the ... ) (Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO ) ...
Cached Medicine Technology:Mederi Therapeutics Announces Receipt of CE Mark for its Second Generation Secca® and Stretta® Systems 2
(Date:3/5/2015)... The global digital PCR (dPCR) and qPCR market ... 7.8% from 2014 to 2019. , The global digital PCR (dPCR) ... 7.8% from 2014 to 2019. Although the mature markets such as ... digital PCR (dPCR) and qPCR market the Asia-Pacific region is expected ... period. The growth of the digital PCR (dPCR) and qPCR market ...
(Date:3/5/2015)... 05, 2015 Risperdal lawsuits ( ... Pennsylvania mass tort litigation currently underway in the ... has begun hearing testimony in the proceeding’s second ... medication can cause gynecomastia, or male breast growth. ... was filed on behalf of a plaintiff who ...
(Date:3/5/2015)... The Maricopa Community Colleges add $7.3 ... economy each year, according to a research report released ... Maricopa County Community College District, summarizes economic impact and ... year 2013-2014. , The analysis was conducted by ... that specializes in providing economic impact studies and labor ...
(Date:3/5/2015)... At the 7th Annual Mississippi Addiction Conference ... met today in Jackson, Mississippi to listen to keynote ... numerous respected speakers will be William S. Jacobs, ... pain medications have had in today’s opiate overdose and ... is hard to believe that much of the current ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Taking ... in Fort Worth, Texas April 9-11th is IDRevolution ... company providing personalized nutrition. IDLife offers a ... IDNutrition. This customized approach to vitamin supplementation ... begins with a free HIPAA compliant online assessment ...
Breaking Medicine News(10 mins):Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 2Health News:Risperdal Lawsuits Move Forward in Pennsylvania, as Bernstein Liebhard LLP Comments on Start of Second Gynecomastia Trial 3Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 2Health News:Maricopa Community Colleges Add $7.3 Billion to Local Economy Annually 3Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:IDLife Partners John C. Maxwell and Troy Aikman speaking at IDRevolution in Fort Worth, TX April 9th-11th, 2015 2
... explanations, study finds , TUESDAY, March 30 (HealthDay News) -- ... trials, most do not receive a clear explanation of their ... report suggests. , In the study, U.S. researchers interviewed 37 ... that more than half of them did not know or ...
... benefit more if they sought advice from doctors, pharmacists, study ... person with knee pain who learns that the cause is ... do the right things to treat it, and probably won,t ... , "Most of the things they did were appropriate," said ...
... ... ... -- Those with aching backs might want to look at their home décor to help ... price range, but many don,t take time to consider products that can actually benefit their ...
... ... ... media company for people who want to live well and do good, today announced three ... YouTube), Jill Beraud (Chief Marketing Officer of Pepsi Americas Beverages & President, Joint Ventures) and ...
... ... , ... 30, 2010 -- Tahitian Noni International (TNI) announced that their 2011 International ... of the Seas, one of the most luxurious cruise ships in the world. The announcement ...
... ... brought over 35 years of experience in industrial fabricating to the medical field. Midbrook ... tables, as well as cleaning and decontamination equipment. , ... (Vocus) March 30, 2010 -- Midbrook, the Jackson, ...
Cached Medicine News:Health News:Many Kids Not Fully Informed of Their Role in Cancer Studies 2Health News:Many With Arthritis Find Simple Solutions for Relief 2Health News:Proper Home Dcor May Assist in Alleviating Back Pain 2Health News:Proper Home Dcor May Assist in Alleviating Back Pain 3Health News:GOOD Adds Depth to Advisory Board 2Health News:Caribbean Cruise Announced by Tahitian Noni International for 2011 2Health News:Midbrook Medical Brings Industrial Experience to Medical Fabrication 2Health News:Midbrook Medical Brings Industrial Experience to Medical Fabrication 3
... TANGO is designed for ... services, donor centers and ... testing and antibody screening. ... host of functions including ...
The ScanGel® automatic readings are done with a high resolution color video camera. Images can be stored and printed....
... Since the early 1990s, the "Reversed" shoulder ... surgeons with great success. More recently, an ... States have begun to champion this prosthesis ... with it. This reversed technology is the ...
... SPEX Fluorolog-3, a spectro-fluorometer ... JOBIN YVON), is a new ... tailored combination of various components. ... customers to freely choose components ...
Medicine Products: